A Novel Mutation in the Second Half of the Keratin 17 1A Domain in a Large Pedigree with Delayed-Onset Pachyonychia Congenita Type 2  by Xiao, Sheng-Xiang et al.
See related Commentary on page x
A Novel Mutation in the Second Half of the Keratin 17 1A
Domain in a Large Pedigree with Delayed-Onset
Pachyonychia Congenita Type 2
Sheng-Xiang Xiao,1 Yi-Guo Feng,1 Xiao-Rong Ren,1 Sheng-Shun Tan, Li Li,w Jun-Min Wang, and
Yao-Zhou Shiz
Department of Dermatology, the Second Hospital, Xi’an Jiaotong University, Shaanxi, China; wDepartment of Dermatology, the Aluke’erqin Qi Hospital,
Autonomous Region of Inner Mongolia, China; zShanghai Bioengineer Research Center, Chinese Academy of Science, Shanghai, China
Pachyonychia congenita type 2 (PC-2), also known as Jackson–Lawler type PC, is an autosomal dominant disorder
characterized by hypertrophic nail dystrophy associated with focal keratoderma and multiple pilosebaceous cysts.
We report a large Chinese pedigree of typical delayed-onset PC-2 that includes 19 affected members. Direct
sequencing of PCR products revealed a novel heterozygous 325A ! G mutation in the affected members. This
mutation predicts the substitution of asparagine by aspartic acid in codon 109 (N109D) located in the second half of
the keratin 17 1A domain, where similar mutation in keratin 5 is associated with the mild Weber–Cockayne form of
epidermolysis bullosa simplex.
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Pachyonychia congenita (PC) consists of a group of
inherited ectodermal disorders characterized by hyper-
trophic nail dystrophy. Two main clinical subtypes of PC
are generally recognized, PC-1 (Jadassohn–Lewandowsky
syndrome, MIM no. 167200) and PC-2 (Jackson–Lawler
syndrome, MIM no. 167210). In PC-1 pachyonychia is
accompanied by severe palmoplantar keratoderma (PPK),
follicular keratoses, and oral leukokeratosis. In PC-2
pachyonychia is also associated with focal PPK and
follicular keratoses but is readily distinguished by the
presence of multiple steatocysts. Usually, since the cysts
normally only appear at puberty, PC-2 is difficult to
distinguish from PC-1 in childhood. The genetic cause of
PC is mutations in four differentiation-specific keratin genes
that are expressed by the affected epithelia. PC-1 is due to
mutations of keratin 16 (K16) gene (McLean et al, 1995) or
its expression partner K6a (Bowden et al, 1995). Similarly,
PC-2 is due to mutations in keratin 17 (K17) gene (McLean
et al, 1995; Smith et al, 1997) or the K6b (Smith et al, 1998).
In classical PC-2, thickening of the nails usually begins
within the first months of life. Clinical observation of some
patients with the onset of the characteristic nail changes of
PC during the second and third decades of life has been
reported in the literature, which are designated ‘‘PC tarda’’
(Paller et al, 1991). To our knowledge, keratin mutation
detected in delayed onset PC has been reported in only one
case of PC-1, which occurred at the central 2B domain of
K16 (Connors et al, 2001). Here, we report a Chinese
pedigree with typical delayed-onset PC-2. A novel mutation
in the second half of the K17 1A domain underlies the
affected members’ phenotype.
Results
The nested PCR produced expected 200 bp DNA fragment.
Direct sequencing of the PCR products revealed a hetero-
zygous 325A ! G mutation in the nine affected members.
This mutation predicts the substitution of asparagine by
aspartic acid in codon 109 (N109D) located in the second
half of the 1A domain (N25D in terms of the 1A domain) of
K17. No such mutation was found in the unaffected member
and 50 unrelated controls (Fig 1). Sequencing of 50
unrelated and unaffected controls’ PCR products excluded
the polymorphism.
Discussion
Keratins are heterodimeric proteins that form the inter-
mediate filament cytoskeleton of epithelial cells. They have
a similar protein structure consisting of a central helical rod
domain, which is responsible for polymerization of these
proteins to form keratin tonofilaments. This rod domain is
subdivided into 1A, 1B, 2A, and 2B segments by flexible
linkers L1, L12, and L2. The sequences at the beginning of
the helix 1A and at the end of the helix 2B are highly
conserved and are the most critical for the assembly of the
intermediate filaments in vivo and in vitro (Fuchs and Weber,
1994; Irvine and Mclean, 1999). K17 is expressed in the nail
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bed, hair follicle, and sebaceous gland (Troyanovsky et al,
1989; McGowan and Coulombe, 2000). We have identified a
novel mutation (N109D) located in the second half of the 1A
domain (N25D in the 1A domain) of K17 in a Chinese
pedigree with delayed-onset PC-2. To date and including
this report, 24 independent mutations have been described
in patients with either PC-2 or steatocystoma multiplex
(Covello et al, 1998; Fujimoto et al, 1998; Celebi et al, 1999;
Smith et al, 2001; Terrinoni et al, 2001; Wang et al, 2001;
Hashiguchi et al, 2002; Feng et al, 2003; www.interfil.org).
They were located in the helix initiation 1A domain of K17
(Fig 2). All previously reported mutations which cause PC
have affected one of the highly conserved sequences at
either end of this helical rod domain common to all keratin
molecules (Munro, 2001), except a mutation in the mid-
region of the 2B helical domain of K16 reported by Connors
et al (2001) in a patient with delayed-onset PC-1.
Interestingly, mutations in the second half of the 1A
domain have been associated with other keratin disorders,
for example equivalent residue in keratin 5 (K5), N193K
(N25K in the 1A domain) causes mild Weber–Cockayne
form of epidermolysis bullosa simplex (EBS) (Humphries
et al, 1996). In EBS, the site of mutation is a strong
determinant of the severity of the phenotype. The most
severe form of EBS with widespread clustered blistering is
the Dowling–Meara variant (EBS-DM). This is predominantly
caused by mutations affecting the helix boundary motifs of
either K5 or K14. In the mild Weber–Cockayne form (EBS-
WC), blisters are mainly found on easily traumatized sites
such as the feet and hands. In this case, the mutations are
located in clusters in the second half of the 1A and 2B
domains, the L12 domain of both K5 and K14 (Irvine and
Mclean, 2003). Furthermore, utilizing an established in vitro
filament disassembly assay, Steinert’s group have shown
that inhibitory peptides analogous to sequences from the
first half of the 1A domain interfere with keratin assembly,
whereas those from the second half of 1A and other internal
sites do not. This implies that the first half of 1A domain is
more important in filament assembly/integrity (Steinert et al,
1993). Thus the identification here of a milder mutation
giving rise to a late-onset form of PC-2 is consistent with the
previous report of delayed onset of PC-1 (Connors et al,
2001), where a mutation was found in the central 2B domain
of K16, a region also associated with milder EBS pheno-
types. On this basis we speculate that the mutation
occurring in the less critical site of the keratins may explain
the delayed onset of PC. In addition to the location of the
mutation within the keratin gene, other genetic or environ-
mental factors could be important in the ultimate clinical
expression (Stratigos and Baden, 2001). It is possible that
modifier genes may promote or delay the onset of
symptoms. A non-mutually exclusive possibility is that
environmental factors may influence the age of disease
presentation.
In conclusion, we report a novel mutation in the second
half of 1A domain of K17 in a large pedigree with delayed-
onset PC-2. More pedigrees of delayed-onset PC need to
be studied to establish the correlation between the site of
mutation in keratin and delayed-onset of pachyonychia.
Subjects, Materials and Methods
The Human Medical and Ethical Committee of Xian Jiaotong
University approved the investigation presented here and all study
subjects gave informed consent. We studied a Chinese pedigree of
delayed-onset PC-2 (Fig 3) from the autonomous region of Inner
Figure 1
Direct automated sequencing of KRT17 gene, showing codon 109
in exon 1. (a) Heterozygous missense mutation 325A ! G. This
mutation predicts the amino acid change asparagine to aspartic acid at
codon 109 (N109D). (b) Sequence in normal subjects. Green, A; black,
G; red, T; blue, C.
Figure 2
Schema of K17 protein structure and summary of reported K17 gene mutations in Pachyonychia congenita type 2 (PC-2). Keratin has helix
domains (1A, 1B, 2A, 2B) separated by linker domains (L1, L12, L2). The DNA and deduced amino acid sequence of the 1A domain are shown. All
previously reported mutations in PC-2 and steatocystoma multiplex are located in the first half (shaded area) of 1A domain of K17, e.g. the helix
initiation 1A domain (www.interfil.org). The mutation reported here in the delayed-onset PC-2 is in the second half (blank) of the 1A domain of K17.
Single-letter abbreviations for the amino acid residues: A, Ala; C, Cys; D, Asp; H, His; K, Lys; L, Leu; M, Met; N, Asn; Q, Gln; R, Arg; S, Ser; T, Thr; V,
Val.Y, Tyr. R94H(2  ), R94C(3  ), and N92S(7  ) indicate that these mutations have been independently reported more than once.
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Mongolian. The proband (female, aged 45 y) in this pedigree
developed thickened toenails at 12 y of age and thickened
fingernails at about 20 y of age. Multiple pilosebaceous cysts
appeared in the axillae, groin area and on the chest and back at
puberty. Most of the cysts are about 2–3 cm in diameter.
Sometimes ulceration occurs and becomes infected. The ulcer-
ated cysts healed with scars. Focal plantar hyperkeratosis
appeared at about 14. The other 18 affected members had
hypertrophic toenails at an age similar to the proband. Twelve of
the 18 affected also had sebaceous cysts at puberty and focal
plantar hyperkeratosis after thickened toenails appeared. Six of
those are teenager patients whose toenails thickened, but finger-
nails still look normal (Fig 4). No natal teeth were found in all the
affected members in the pedigree. Fungal examination under
microscope and obvious family history exclude onychomychosis.
Five milliliters of peripheral blood was obtained from the
proband, eight affected members, one unaffected member in the
pedigree, and 50 unrelated and unaffected people. The genomic
DNA was extracted with a whole blood genomic DNA extracting kit
(Sino-American Bioengineer Company, Luoyang, China) and used
as template for PCR-mediated amplification of exon 1 of the K17
gene. The primers (K17p8 and K17p10) and PCR conditions are
described in the literature (McLean et al, 1995). The PCR products
were diluted and used as template in the nested PCR whose
primer sequences are as follows: the forward primer 50-GCT GCT
ACA GCT TTG GCT CT-30 and the reverse primer 50-CAC GAC GTT
GTA AAA CGA CCA GTC ACG GAT CTT CAC C-30. Sequence
analyses were performed using Big Dye terminator chemistry on an
ABI 377 genetic analyzer (Perkin-Elmer-Cetus Instruments, Nor-
walk, Connecticut). Sequences were compared with those of one
unaffected, and 50 unrelated and unaffected samples.
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